An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders

Table 4

Engagement with MCR-Q and pharmacotherapy and completion of follow-up assessments.

Measure	(%)
Engagement with intervention
MCR-Q
100% of sessions completed	32 (66.7%)
81-99% of sessions completed	2 (4.1%)
50-80% of sessions completed	3 (6.3%)
< 50% of sessions completed	11 (22.9%)
Pharmacotherapy
81-100% of sessions where pharmacotherapy was used	33 (68.8%)
50-80% of sessions where pharmacotherapy was used	6 (12.5)
< 50% of sessions where pharmacotherapy was used	3 (6.3%)
Pharmacotherapy was never used	6 (12.5%)
Follow-up
8-week follow-up
Completed	33 (68.7%)
No show	12 (25.0%)
Withdrew from study	3 (6.3%)
13-week follow-up
Completed	31 (64.6%)
No show	14 (29.1%)
Withdrew from study	3 (6.3%)